Email this page

The ordinary shares and American Depositary Shares (“ADSs”) will trade ex-dividend on both the London and New York Stock Exchanges from 14 October 2009 and the record date will be 16 October 2009 in respect of the first interim dividend for the year ended 31 December 2009 of 5.46¢ per ordinary share to be paid on 3 November 2009. All shareholders with a UK address on the share register will receive their dividend in sterling. The rate of which will be determined shortly after the record date. Shareholders who wish their dividends to be paid directly to a bank or building society and who have not already completed a BACS mandate should contact the Company’s registrars Equiniti (formerly Lloyds TSB Registrars).

The Company has a dividend re-investment plan that offers shareholders, except those in North America, the opportunity to invest their cash dividends in further Smith & Nephew ordinary shares, which are purchased in the market at competitive dealing costs. Application forms for re-investing dividends are available from Equiniti who administer the plan on behalf of the Company.

For the purposes of capital gains tax the price of ordinary shares on 31 March 1982 was 35.04p.

The Company’s ordinary shares are quoted on the London Stock Exchange under the symbol SN. The Company’s share price is available on the Smith & Nephew website www.smith-nephew.com  and on the London Stock Exchange website at  www.londonstockexchange.com, where it is updated at regular intervals throughout the day. It is also quoted daily in UK national newspapers.

For information about the AGM, shareholdings, dividends and changes to personal details all shareholders should contact Equiniti, Aspect House, Spencer Road, Lancing, West Sussex BN99 6DA, UK. Telephone 0871 384 2081 (Calls to this number are charged at 8p per minute from a BT landline. Other telephony providers costs may vary) or +44 (0)121 415 7072 if calling from outside the UK.

In the US, the Company’s ordinary shares are traded in the form of American Depositary Shares ("ADSs") evidenced by ADRs, and trade on the NYSE under the symbol SNN. Each ADS represents five ordinary shares. The Bank of New York Mellon is the authorised depositary bank for the Company’s ADR programme. A Global BuyDIRECT plan is available for US residents, enabling investment directly in ADSs with reduced brokerage commissions and service costs. For further information on Global BuyDIRECT contact: The Bank of New York Mellon on +1-866-259-2287 (toll-free) or visit the Bank of New York Mellon website at  http://www.adrbnymellon.com.

The Company’s ADS price can be obtained from the official New York Stock Exchange website at www.nyse.com  and is quoted daily in the Wall Street Journal.

All enquiries regarding ADS holder accounts and payment of dividends should be addressed to BNY Mellon Shareowner Services, PO Box 358516, Pittsburgh PA 15252-8516. Toll free in USA 1-866-259-2287. International calls +1 201 680 6825.

Quarter one results announced and AGM	30 April 2009
Payment of 2008 second interim dividend	8 May 2009
Half year results announced	30 July 2009*
Quarter three results announced	6 November 2009
Payment of 2009 first interim dividend	3 November 2009
Full year results announced	12 February 2009*
Annual Report available	27 March 2009

* Dividend declaration dates

The Company’s Annual General Meeting was held on 30 April 2009 at 11am at The Royal College of Physicians, 11 St Andrew's Place, Regents Park, NW1 4LE. Notice of the meeting was sent to all shareholders with an accompanying letter from the Chairman.

The corporate headquarters is in the UK and the registered office address is:

Smith & Nephew plc,
15 Adam Street,
London WC2N 6LA, UK.
Registered in England and Wales No. 324357.
Tel: +44 (0) 20 7401 7646.
Website: www.smith-nephew.com.